-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio Oncology awards employee stock options for 32,675 shares at $7.66

PUBT·05/12/2026 20:08:56
Listen to the news
BridgeBio Oncology awards employee stock options for 32,675 shares at $7.66
  • BridgeBio Oncology Therapeutics awarded inducement equity compensation on May 10, 2026 to one employee hired in March 2026.
  • Grant comprised non-qualified stock options covering 32,675 shares, struck at USD 7.66 per share.
  • Vesting set at 25% on first anniversary of start date, remaining portion in 36 equal monthly installments, contingent on continued service.
  • Awards issued under company’s 2025 Inducement Plan, adopted in October 2025, outside stockholder-approved equity incentive plans.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605121605PRIMZONEFULLFEED9718093) on May 12, 2026, and is solely responsible for the information contained therein.